Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Harvard Business School
AstraZeneca
McKinsey
Cantor Fitzgerald
Argus Health
Mallinckrodt
Baxter
Citi

Generated: February 25, 2018

DrugPatentWatch Database Preview

Phenylbutazone - Generic Drug Details

« Back to Dashboard

Medical Subject Heading (MeSH) Categories for phenylbutazone

US Patents and Regulatory Information for phenylbutazone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PHENYLBUTAZONE phenylbutazone TABLET;ORAL 086151-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis BUTAZOLIDIN phenylbutazone TABLET;ORAL 008319-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs PHENYLBUTAZONE phenylbutazone TABLET;ORAL 087674-001 Apr 21, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs PHENYLBUTAZONE phenylbutazone CAPSULE;ORAL 087756-001 Dec 17, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fosun Pharma PHENYLBUTAZONE phenylbutazone CAPSULE;ORAL 087774-001 Jun 16, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Pharms PHENYLBUTAZONE phenylbutazone CAPSULE;ORAL 088218-001 Jun 24, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fosun Pharma PHENYLBUTAZONE phenylbutazone TABLET;ORAL 084339-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis BUTAZOLIDIN phenylbutazone CAPSULE;ORAL 008319-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us AZOLID phenylbutazone TABLET;ORAL 087091-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries PHENYLBUTAZONE phenylbutazone TABLET;ORAL 088863-001 Dec 4, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
Healthtrust
Cipla
Johnson and Johnson
Daiichi Sankyo
McKinsey
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot